BioControl Becomes Latest Company To Report Disappointing Outcomes With VNS Therapy For Heart Failure
This article was originally published in Clinica
Executive Summary
BioControl Medical has terminated the INOVATE HF trial of its CardioFit vagus nerve stimulator (VNS) for the treatment of heart failure, after a pre-specified interim analysis showed the trial had little chance of meeting its primary endpoint.